Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment
Commerce and Industry Minister Piyush Goyal on Sunday held an interaction with bosses of various pharmaceutical industry companies and representatives of the sector-related bodies. During the interaction, Mr Goyal lauded the pharma industry for its efforts during the prevailing COVID-19 crisis and said that India has been recognised as the ‘Pharmacy of the World', for providing essential medicines to over 120 countries during the last two months. Mr Goyal also said that the anti-dumping investigation process has been expedited. and assured the industry bosses of prompt remedial action in case of any roadblock or any instance of unfair competition. He informed the gathering that the government has decided to disinvest in certain pharma industry PSUs, and invited the companies to use PSUs for plug and play model of manufacturing.
The minister assured the industry of the government's support in its expansion, diversification and strengthening, adding that the pharma industry has an important role to play in the Aatmanirbhar Bharat campaign.
The meeting, held through video conferencing was also attended by junior ministers and secretaries of the health and commerce ministries.
The minister also said that the country has adequate production capacity and abundant stock of hydroxychloroquine and paracetamol for its projected domestic requirements and putting restrictions on their exports is a measure to ensure that the medicines are made available to all the needy nations and no unscrupulous element stocks them for unwarranted gains.
Mr Goyal also claimed that early announcement of the lockdown helped the country in preventing and containing the scourge of pandemic, and also scaling up the health infrastructure and build capacity.Â
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.